Close

Analyst Ratings for ABIOMED (ABMD) [Buys]

ABMD Rating Summary

  |   Expand Research on ABMD
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3.7 / 10   Percentile Rank: 35%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/13/2022 Mizuho Anthony Petrone New Coverage Buy
(N/A)
300.00
(N/A)
243.14
(381.02)
56.71% Details
4/4/2018 Goldman Sachs N/A New Coverage Buy
(N/A)
332.00
(N/A)
279.11
(381.02)
36.51% Details